Heterozygous mutations in glucosylceramidase beta (GBA), a lysosomal enzyme that converts glucosylceramide to ceramide and glucose, is one of the most common genetic risk factors for PD pathogenesis, contributing to 7–20% of all PD cases (Stoker et al., 2018). The gene discussed is GBA1; the disease is Parkinson disease.